It should be mentioned that, though the potency of DMF in preventing acinar destruction was identified in multiple rat pancreatitis models, there have been no human clinical trials using Nrf2 activators to treat AP or CP as of yet. Here, NFE2L2 is linked to alkaline phosphatase measurement.